Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · Real-Time Price · USD

1.100

-0.020 (-1.79%)

At close: May 12, 2025, 4:00 PM

1.110

+0.010 (0.90%)

After-hours: May 12, 2025, 7:59 PM EDT

PACB Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	152.36	154.01	200.52	128.3	130.51	78.89	Upgrade
Revenue Growth (YoY)	-23.98%	-23.19%	56.29%	-1.69%	65.43%	-13.20%	Upgrade
Cost of Revenue	102.04	106.34	142.32	74.83	71.35	46.33	Upgrade
Gross Profit	50.32	47.67	58.2	53.47	59.17	32.57	Upgrade
Selling, General & Admin	171.43	175.02	169.82	160.85	124.12	72.8	Upgrade
Research & Development	120.52	134.92	187.17	193	112.9	64.15	Upgrade
Other Operating Expenses	1.27	1	3.44	3.71	-	-	Upgrade
Operating Expenses	320.9	338.34	368.56	358.29	237.33	136.95	Upgrade
Operating Income	-270.58	-290.66	-310.37	-304.82	-178.16	-104.39	Upgrade
Interest Expense	-11.57	-13.41	-14.34	-14.69	-12.53	-0.27	Upgrade
Other Non Operating Income (Expenses)	8.27	10.74	19.84	7.39	4.1	1.95	Upgrade
EBT Excluding Unusual Items	-273.88	-293.34	-304.86	-312.12	-186.59	-102.7	Upgrade
Merger & Restructuring Charges	-386.29	-	-9.04	-	-83.13	34	Upgrade
Impairment of Goodwill	-144.5	-144.5	-	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	13.04	13.04	12.84	0.24	-4.01	0.11	Upgrade
Asset Writedown	-40	-40	-	-	-	-	Upgrade
Other Unusual Items	173.89	155.26	-17.09	-2.38	-1.14	98	Upgrade
Pretax Income	-657.73	-309.54	-318.16	-314.25	-274.87	29.4	Upgrade
Income Tax Expense	0.01	0.32	-11.42	-	-93.65	-	Upgrade
Net Income	-657.75	-309.85	-306.74	-314.25	-181.22	29.4	Upgrade
Net Income to Common	-657.75	-309.85	-306.74	-314.25	-181.22	29.4	Upgrade
Shares Outstanding (Basic)	281	274	254	225	204	165	Upgrade
Shares Outstanding (Diluted)	281	274	254	225	204	175	Upgrade
Shares Change (YoY)	7.98%	8.22%	12.95%	10.00%	16.67%	14.71%	Upgrade
EPS (Basic)	-2.34	-1.13	-1.21	-1.40	-0.89	0.18	Upgrade
EPS (Diluted)	-2.34	-1.13	-1.21	-1.40	-0.89	0.17	Upgrade
Free Cash Flow	-	-212.25	-268.02	-279.96	-117.11	18.46	Upgrade
Free Cash Flow Per Share	-	-0.77	-1.06	-1.25	-0.57	0.11	Upgrade
Gross Margin	33.03%	30.95%	29.02%	41.68%	45.33%	41.28%	Upgrade
Operating Margin	-177.59%	-188.73%	-154.78%	-237.58%	-136.51%	-132.31%	Upgrade
Profit Margin	-431.71%	-201.18%	-152.97%	-244.93%	-138.85%	37.27%	Upgrade
Free Cash Flow Margin	-	-137.81%	-133.66%	-218.20%	-89.73%	23.40%	Upgrade
EBITDA	-229.19	-249.48	-290.64	-294.43	-170.58	-97.96	Upgrade
EBITDA Margin	-150.43%	-161.98%	-144.94%	-229.47%	-130.70%	-124.16%	Upgrade
D&A For EBITDA	41.39	41.19	19.72	10.39	7.58	6.43	Upgrade
EBIT	-270.58	-290.66	-310.37	-304.82	-178.16	-104.39	Upgrade
EBIT Margin	-177.59%	-188.73%	-154.78%	-237.58%	-136.51%	-132.31%	Upgrade
Revenue as Reported	152.36	154.01	200.52	128.3	130.51	78.89	Upgrade

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q